Long-Term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme a Reductase Inhibitors

Archives of Internal Medicine

doi 10.1001/archinte.160.15.2273

Full Text

Abstract

Available in

Date

August 14, 2000

Authors

Michael Bottorff

Publisher

American Medical Association (AMA)

Related search

Inhibitors of Hydroxymethylglutaryl Coenzyme a Reductase for Treating Hypercholesterolaemia.

English

3-Hydroxy-3-Methylglutaryl–coenzyme a Reductase Inhibitors (Statins) Induce Hepatic Expression of the Phospholipid Translocase Mdr2 in Rats

Gastroenterology

Gastroenterology

English

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors

Journal of Clinical Medicine Research

English

Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitors

Cardiovascular Medicine

English

Effect of Hydroxymethylglutaryl Coenzyme a Reductase Inhibitors on the Progression of Calcific Aortic Stenosis

Cardiovascular Medicine

English

3-Hydroxy-3-Methyl Glutaryl Coenzyme a Reductase Inhibition Modulates Vasopressin-Stimulated Ca2+ Responses in Rat A10 Vascular Smooth Muscle Cells

Circulation Research

Cardiovascular Medicine

Latin

3-Hydroxy-3 Methyl Glutaryl Coenzyme a (Hmg Coa) Reductase Activity in Fibroblasts From Phenotypic Homozygous Type Ii Hy-Perlipoproteinemia (Hhlpii)

Pediatric Research

English

Varicose Remodeling of Veins Is Suppressed by 3‐Hydroxy‐3‐Methylglutaryl Coenzyme a Reductase Inhibitors

Journal of the American Heart Association

Cardiovascular Medicine

English

Pharmacokinetic Interactions Between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitors Atorvastatin and Simvastatin

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English